Mainz Biomed B.V. Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	7.07	17.14	8.73	0.12	0.2
Cash & Cash Equivalents	7.07	17.14	8.73	0.12	0.2
Cash Growth	-58.75%	96.41%	7020.57%	-39.80%	-
Receivables	0.09	0.07	0.11	0.04	0.04
Inventory	0.61	0.18	0	0	0
Other Current Assets	1.2	0.99	0.77	0.02	0.02
Total Current Assets	8.98	18.38	9.61	0.19	0.26
Property, Plant & Equipment	3.03	1.84	0.43	0.49	0.46
Goodwill and Intangibles	3.39	0	0	0	0
Other Long-Term Assets	0	0.02	0	0	0
Total Long-Term Assets	6.43	1.86	0.43	0.49	0.46
Total Assets	15.41	20.24	10.04	0.67	0.72
Accounts Payable	3.48	2.72	0.87	0.4	0.25
Deferred Revenue	0.14	0.2	0	0	0
Current Debt	5.22	0.36	0.25	0.27	0.21
Other Current Liabilities	0.39	0.97	0.23	0.03	0
Total Current Liabilities	9.24	4.24	1.35	0.7	0.46
Long-Term Debt	1.17	0.96	0.39	0.89	0.79
Other Long-Term Liabilities	1.76	0.94	1.94	1.82	1.42
Total Long-Term Liabilities	2.92	1.9	2.33	2.71	2.21
Total Liabilities	12.16	6.14	3.68	3.41	2.67
Total Debt	6.39	1.32	0.64	1.16	0.99
Debt Growth	384.24%	107.41%	-45.21%	16.72%	-
Retained Earnings	-69.33	-43.03	-16.64	-4.95	-4.37
Comprehensive Income	-0.45	0.05	0	-0.2	0.02
Shareholders' Equity	3.25	14.1	6.36	-2.74	-1.95
Net Cash / Debt	0.68	15.82	8.09	-1.04	-0.79
Net Cash / Debt Growth	-95.70%	95.54%	-	-	-
Net Cash Per Share	0.04	1.12	1.12	-0.19	-0.14
Working Capital	-0.26	14.14	8.26	-0.52	-0.2
Book Value Per Share	0.20	1.00	0.88	-0.49	-0.35

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).